{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:59Z","timestamp":1789448579198,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac magnetic resonance (CMR) plays an essential role in identifying the underlying etiology of myocardial infarction with non-obstructive coronary arteries (MINOCA). However, risk stratification in patients with CMR-confirmed MINOCA remains insufficiently defined. Soluble suppression of tumorigenicity 2 (sST2), a biomarker related to myocardial fibrosis and adverse cardiac remodeling, may provide additional prognostic information in this population. This study aimed to evaluate the prognostic value of sST2 in patients with CMR-confirmed MINOCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study included patients suspected of MI who underwent coronary angiography and completed CMR during hospitalization. MACE included all-cause death, recurrent MI, stroke, heart failure, arrhythmia, and angina pectoris. MINOCA was defined by evidence of ischemia or infarction on CMR. sST2 was tested using an immunoassay kit according to the protocol during hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 97 patients with CMR-confirmed MINOCA were included. During a median follow-up of 24.2 months, 33 patients experienced MACE. Patients with MACE had significantly higher sST2 levels and worse CMR parameters, including lower left ventricular ejection fraction, greater late gadolinium enhancement extent, larger left ventricular end-systolic volume index, and impaired global longitudinal strain (GLS). Multivariable Cox regression analysis showed that sST2 (HR 1.010, 95% CI 1.003\u20131.017,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005) and GLS (HR 0.864, 95% CI 0.780\u20130.956,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005) were independently associated with MACE. Receiver operating characteristic analysis demonstrated moderate predictive performance for sST2, with an area under the curve of 0.696. Kaplan\u2013Meier analysis showed that patients with sST2\u2009\u2265\u200936.95\u2005ng\/mL had a significantly higher risk of MACE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated sST2 is independently associated with adverse outcomes in patients with CMR-confirmed MINOCA. sST2 may serve as a practical biomarker for risk stratification in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1917954","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:24Z","timestamp":1789446444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of soluble ST2 in cardiac magnetic resonance defined myocardial infarction with non-obstructive coronary arteries"],"prefix":"10.3389","volume":"13","author":[{"given":"Chenchen","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e003443","DOI":"10.1161\/CIRCOUTCOMES.116.003443","article-title":"Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines)","volume":"10","author":"Smilowitz","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4329\/wjr.v9.i6.280","article-title":"Cardiac magnetic resonance in patients with acute cardiac injury and unobstructed coronary arteries","volume":"9","author":"Camastra","year":"2017","journal-title":"World J Radiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2796.2012.02567.x","article-title":"Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm myocardial infarction with normal coronaries study","volume":"273","author":"Collste","year":"2013","journal-title":"J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.acvd.2011.01.005","article-title":"Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries","volume":"104","author":"Leurent","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.mayocp.2020.11.026","article-title":"Prognostic value of cardiac magnetic resonance imaging in acute coronary syndrome patients with troponin elevation and nonobstructive coronary arteries","volume":"96","author":"Luis","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jcmg.2018.12.023","article-title":"Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries","volume":"12","author":"Dastidar","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jcmg.2022.12.029","article-title":"Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis","volume":"16","author":"Mileva","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijcard.2021.11.088","article-title":"Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging","volume":"349","author":"Ananthakrishna","year":"2022","journal-title":"Int J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/eurheartj\/ehu469","article-title":"Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management","volume":"36","author":"Niccoli","year":"2015","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","article-title":"Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s10741-022-10258-2","article-title":"Soluble ST2: a valuable prognostic marker in heart failure","volume":"27","author":"Savarimuthu","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/jcm8020270","article-title":"Cardiac biomarkers in the emergency department: the role of soluble ST2 (sST2) in acute heart failure and acute coronary syndrome-there is meat on the bone","volume":"8","author":"Aleksova","year":"2019","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5935\/abc.20150151","article-title":"Soluble ST2 testing: a promising biomarker in the management of heart failure","volume":"106","author":"Villacorta","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation\/American Heart Association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/j.ijcard.2013.12.101","article-title":"Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction","volume":"172","author":"Gruson","year":"2014","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e039395","DOI":"10.1161\/JAHA.124.039395","article-title":"Prognostic value of strain by tissue tracking cardiac magnetic resonance in myocardial infarction with nonobstructive coronary arteries","volume":"14","author":"Chen","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jmri.28491","article-title":"Cardiac MRI left atrial strain associated with new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction","volume":"58","author":"Chen","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/eurheartj\/ehaa624","article-title":"The \u2018ten Commandments\u2019 for the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"41","author":"Collet","year":"2020","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International expert consensus document on takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/01.CIR.0000036368.63317.1C","article-title":"Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging","volume":"106","author":"Mahrholdt","year":"2002","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jcmg.2021.02.021","article-title":"Early comprehensive cardiovascular magnetic resonance imaging in patients with myocardial infarction with nonobstructive coronary arteries","volume":"14","author":"S\u00f6rensson","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/heartjnl-2023-322835","article-title":"Imaging patients with myocardial infarction with non-obstructive coronary arteries (MINOCA)","volume":"110","author":"Leo","year":"2024","journal-title":"Heart"},{"key":"B30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cjca.2023.04.009","article-title":"Role of cardiac magnetic resonance imaging and troponin T in definitive diagnosis of myocardial infarction with nonobstructive coronary arteries (MINOCA)","volume":"39","author":"Yu","year":"2023","journal-title":"Can J Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e016463","DOI":"10.1161\/CIRCIMAGING.123.016463","article-title":"How to use cardiac magnetic resonance imaging in myocardial infarction with nonobstructive coronary arteries","volume":"17","author":"Tornvall","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/2048872619896063","article-title":"Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction","volume":"9","author":"Frydland","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","article-title":"Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction","volume":"55","author":"Weir","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.107.728022","article-title":"Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction","volume":"117","author":"Sabatine","year":"2008","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ahj.2018.03.005","article-title":"Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries","volume":"200","author":"Hjort","year":"2018","journal-title":"Am Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.2147\/JIR.S482596","article-title":"Prognostic value of systemic inflammation response Index and N-terminal pro-B-type natriuretic peptide in patients with myocardial infarction with nonobstructive coronary arteries-A retrospective study","volume":"17","author":"Hou","year":"2024","journal-title":"J Inflamm Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4330\/wjc.v14.i4.190","article-title":"Role of cardiac magnetic resonance imaging in troponinemia syndromes","volume":"14","author":"Nguyen Nguyen","year":"2022","journal-title":"World J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.120.052008","article-title":"Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women","volume":"143","author":"Reynolds","year":"2021","journal-title":"Circulation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1917954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:27:25Z","timestamp":1789446445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1917954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2026.1917954"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1917954","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1917954"}}